ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic BCG Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-5X15087
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Therapeutic BCG Vaccines Market Insights Forecast to 2029
BUY CHAPTERS

Global Therapeutic BCG Vaccines Market Research Report 2025

Code: QYRE-Auto-5X15087
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur (Sanofi)
Japan BCG Lab
Serum Institute of India
Intervax
GSBPL
Merck

Therapeutic BCG Vaccines Market Size

The global market for Therapeutic BCG Vaccines was valued at US$ 362 million in the year 2024 and is projected to reach a revised size of US$ 441 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Therapeutic BCG Vaccines Market

Therapeutic BCG Vaccines Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic BCG Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic BCG Vaccines.
The Therapeutic BCG Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic BCG Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic BCG Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic BCG Vaccines Market Report

Report Metric Details
Report Name Therapeutic BCG Vaccines Market
Accounted market size in year US$ 362 million
Forecasted market size in 2031 US$ 441 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 0.5ml Package
  • 1ml Package
  • 2ml Package
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Sanofi Pasteur (Sanofi), Japan BCG Lab, Serum Institute of India, Intervax, GSBPL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic BCG Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic BCG Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Therapeutic BCG Vaccines Market growing?

Ans: The Therapeutic BCG Vaccines Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Therapeutic BCG Vaccines Market size in 2031?

Ans: The Therapeutic BCG Vaccines Market size in 2031 will be US$ 441 million.

Who are the main players in the Therapeutic BCG Vaccines Market report?

Ans: The main players in the Therapeutic BCG Vaccines Market are Merck, Sanofi Pasteur (Sanofi), Japan BCG Lab, Serum Institute of India, Intervax, GSBPL

What are the Application segmentation covered in the Therapeutic BCG Vaccines Market report?

Ans: The Applications covered in the Therapeutic BCG Vaccines Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Therapeutic BCG Vaccines Market report?

Ans: The Types covered in the Therapeutic BCG Vaccines Market report are 0.5ml Package, 1ml Package, 2ml Package, Others

Recommended Reports

Vaccine Market

Vaccine Devices & Packaging

Therapeutic & Specialized Vaccines

1 Therapeutic BCG Vaccines Market Overview
1.1 Product Definition
1.2 Therapeutic BCG Vaccines by Type
1.2.1 Global Therapeutic BCG Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5ml Package
1.2.3 1ml Package
1.2.4 2ml Package
1.2.5 Others
1.3 Therapeutic BCG Vaccines by Application
1.3.1 Global Therapeutic BCG Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Therapeutic BCG Vaccines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic BCG Vaccines Revenue 2020-2031
1.4.2 Global Therapeutic BCG Vaccines Sales 2020-2031
1.4.3 Global Therapeutic BCG Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Therapeutic BCG Vaccines Market Competition by Manufacturers
2.1 Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Therapeutic BCG Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Therapeutic BCG Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Therapeutic BCG Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic BCG Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Therapeutic BCG Vaccines, Date of Enter into This Industry
2.8 Global Therapeutic BCG Vaccines Market Competitive Situation and Trends
2.8.1 Global Therapeutic BCG Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Therapeutic BCG Vaccines Players Market Share by Revenue
2.8.3 Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic BCG Vaccines Market Scenario by Region
3.1 Global Therapeutic BCG Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Therapeutic BCG Vaccines Sales by Region: 2020-2031
3.2.1 Global Therapeutic BCG Vaccines Sales by Region: 2020-2025
3.2.2 Global Therapeutic BCG Vaccines Sales by Region: 2026-2031
3.3 Global Therapeutic BCG Vaccines Revenue by Region: 2020-2031
3.3.1 Global Therapeutic BCG Vaccines Revenue by Region: 2020-2025
3.3.2 Global Therapeutic BCG Vaccines Revenue by Region: 2026-2031
3.4 North America Therapeutic BCG Vaccines Market Facts & Figures by Country
3.4.1 North America Therapeutic BCG Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Therapeutic BCG Vaccines Sales by Country (2020-2031)
3.4.3 North America Therapeutic BCG Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic BCG Vaccines Market Facts & Figures by Country
3.5.1 Europe Therapeutic BCG Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Therapeutic BCG Vaccines Sales by Country (2020-2031)
3.5.3 Europe Therapeutic BCG Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic BCG Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic BCG Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Therapeutic BCG Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic BCG Vaccines Market Facts & Figures by Country
3.7.1 Latin America Therapeutic BCG Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Therapeutic BCG Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Therapeutic BCG Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic BCG Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic BCG Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic BCG Vaccines Sales by Type (2020-2031)
4.1.1 Global Therapeutic BCG Vaccines Sales by Type (2020-2025)
4.1.2 Global Therapeutic BCG Vaccines Sales by Type (2026-2031)
4.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Therapeutic BCG Vaccines Revenue by Type (2020-2031)
4.2.1 Global Therapeutic BCG Vaccines Revenue by Type (2020-2025)
4.2.2 Global Therapeutic BCG Vaccines Revenue by Type (2026-2031)
4.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Therapeutic BCG Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Therapeutic BCG Vaccines Sales by Application (2020-2031)
5.1.1 Global Therapeutic BCG Vaccines Sales by Application (2020-2025)
5.1.2 Global Therapeutic BCG Vaccines Sales by Application (2026-2031)
5.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Therapeutic BCG Vaccines Revenue by Application (2020-2031)
5.2.1 Global Therapeutic BCG Vaccines Revenue by Application (2020-2025)
5.2.2 Global Therapeutic BCG Vaccines Revenue by Application (2026-2031)
5.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Therapeutic BCG Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Therapeutic BCG Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur (Sanofi)
6.2.1 Sanofi Pasteur (Sanofi) Company Information
6.2.2 Sanofi Pasteur (Sanofi) Description and Business Overview
6.2.3 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Portfolio
6.2.5 Sanofi Pasteur (Sanofi) Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Company Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Japan BCG Lab Therapeutic BCG Vaccines Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Company Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute of India Therapeutic BCG Vaccines Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Intervax
6.5.1 Intervax Company Information
6.5.2 Intervax Description and Business Overview
6.5.3 Intervax Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Intervax Therapeutic BCG Vaccines Product Portfolio
6.5.5 Intervax Recent Developments/Updates
6.6 GSBPL
6.6.1 GSBPL Company Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSBPL Therapeutic BCG Vaccines Product Portfolio
6.6.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic BCG Vaccines Industry Chain Analysis
7.2 Therapeutic BCG Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic BCG Vaccines Production Mode & Process Analysis
7.4 Therapeutic BCG Vaccines Sales and Marketing
7.4.1 Therapeutic BCG Vaccines Sales Channels
7.4.2 Therapeutic BCG Vaccines Distributors
7.5 Therapeutic BCG Vaccines Customer Analysis
8 Therapeutic BCG Vaccines Market Dynamics
8.1 Therapeutic BCG Vaccines Industry Trends
8.2 Therapeutic BCG Vaccines Market Drivers
8.3 Therapeutic BCG Vaccines Market Challenges
8.4 Therapeutic BCG Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur (Sanofi)
Japan BCG Lab
Serum Institute of India
Intervax
GSBPL
Merck
List of Tables
 Table 1. Global Therapeutic BCG Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Therapeutic BCG Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Therapeutic BCG Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Therapeutic BCG Vaccines Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Therapeutic BCG Vaccines Average Price (USD/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Therapeutic BCG Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Therapeutic BCG Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Therapeutic BCG Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Therapeutic BCG Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic BCG Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Therapeutic BCG Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Therapeutic BCG Vaccines Sales by Region (2020-2025) & (Kg)
 Table 18. Global Therapeutic BCG Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Therapeutic BCG Vaccines Sales by Region (2026-2031) & (Kg)
 Table 20. Global Therapeutic BCG Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Therapeutic BCG Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Therapeutic BCG Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Therapeutic BCG Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Therapeutic BCG Vaccines Sales by Country (2020-2025) & (Kg)
 Table 27. North America Therapeutic BCG Vaccines Sales by Country (2026-2031) & (Kg)
 Table 28. North America Therapeutic BCG Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Therapeutic BCG Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Therapeutic BCG Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Therapeutic BCG Vaccines Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Therapeutic BCG Vaccines Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Therapeutic BCG Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Therapeutic BCG Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Therapeutic BCG Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Therapeutic BCG Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Therapeutic BCG Vaccines Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Therapeutic BCG Vaccines Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Therapeutic BCG Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Therapeutic BCG Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Therapeutic BCG Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Therapeutic BCG Vaccines Sales (Kg) by Type (2020-2025)
 Table 51. Global Therapeutic BCG Vaccines Sales (Kg) by Type (2026-2031)
 Table 52. Global Therapeutic BCG Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Therapeutic BCG Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2020-2025)
 Table 59. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2026-2031)
 Table 60. Global Therapeutic BCG Vaccines Sales (Kg) by Application (2020-2025)
 Table 61. Global Therapeutic BCG Vaccines Sales (Kg) by Application (2026-2031)
 Table 62. Global Therapeutic BCG Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Therapeutic BCG Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2020-2025)
 Table 69. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 73. Merck Therapeutic BCG Vaccines Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Sanofi Pasteur (Sanofi) Company Information
 Table 76. Sanofi Pasteur (Sanofi) Description and Business Overview
 Table 77. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 78. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product
 Table 79. Sanofi Pasteur (Sanofi) Recent Developments/Updates
 Table 80. Japan BCG Lab Company Information
 Table 81. Japan BCG Lab Description and Business Overview
 Table 82. Japan BCG Lab Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 83. Japan BCG Lab Therapeutic BCG Vaccines Product
 Table 84. Japan BCG Lab Recent Developments/Updates
 Table 85. Serum Institute of India Company Information
 Table 86. Serum Institute of India Description and Business Overview
 Table 87. Serum Institute of India Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. Serum Institute of India Therapeutic BCG Vaccines Product
 Table 89. Serum Institute of India Recent Developments/Updates
 Table 90. Intervax Company Information
 Table 91. Intervax Description and Business Overview
 Table 92. Intervax Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 93. Intervax Therapeutic BCG Vaccines Product
 Table 94. Intervax Recent Developments/Updates
 Table 95. GSBPL Company Information
 Table 96. GSBPL Description and Business Overview
 Table 97. GSBPL Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 98. GSBPL Therapeutic BCG Vaccines Product
 Table 99. GSBPL Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Therapeutic BCG Vaccines Distributors List
 Table 103. Therapeutic BCG Vaccines Customers List
 Table 104. Therapeutic BCG Vaccines Market Trends
 Table 105. Therapeutic BCG Vaccines Market Drivers
 Table 106. Therapeutic BCG Vaccines Market Challenges
 Table 107. Therapeutic BCG Vaccines Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Therapeutic BCG Vaccines
 Figure 2. Global Therapeutic BCG Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Therapeutic BCG Vaccines Market Share by Type: 2024 & 2031
 Figure 4. 0.5ml Package Product Picture
 Figure 5. 1ml Package Product Picture
 Figure 6. 2ml Package Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Therapeutic BCG Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Therapeutic BCG Vaccines Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Others
 Figure 13. Global Therapeutic BCG Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Therapeutic BCG Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Therapeutic BCG Vaccines Sales (2020-2031) & (Kg)
 Figure 16. Global Therapeutic BCG Vaccines Average Price (USD/g) & (2020-2031)
 Figure 17. Therapeutic BCG Vaccines Report Years Considered
 Figure 18. Therapeutic BCG Vaccines Sales Share by Manufacturers in 2024
 Figure 19. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Therapeutic BCG Vaccines Players: Market Share by Revenue in Therapeutic BCG Vaccines in 2024
 Figure 21. Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Therapeutic BCG Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Therapeutic BCG Vaccines Sales Market Share by Country (2020-2031)
 Figure 24. North America Therapeutic BCG Vaccines Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Therapeutic BCG Vaccines Sales Market Share by Country (2020-2031)
 Figure 28. Europe Therapeutic BCG Vaccines Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Therapeutic BCG Vaccines Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Therapeutic BCG Vaccines Revenue Market Share by Region (2020-2031)
 Figure 36. China Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Therapeutic BCG Vaccines Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Therapeutic BCG Vaccines Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Therapeutic BCG Vaccines Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Therapeutic BCG Vaccines Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Therapeutic BCG Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Therapeutic BCG Vaccines by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Therapeutic BCG Vaccines by Type (2020-2031)
 Figure 58. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Therapeutic BCG Vaccines by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Therapeutic BCG Vaccines by Application (2020-2031)
 Figure 61. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2020-2031)
 Figure 62. Therapeutic BCG Vaccines Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Livestock Vaccine Market Research Report 2025
Global Vaccine Cooler Market Research Report 2025
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Global Attenuated Vaccine Market Research Report 2025
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Tuberculosis Vaccine Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Influenza Vaccine Market
Clostridium Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bordetella Vaccine for Dogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aluminum based Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Bordetella Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions